Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Get started with wealth management for beginners in 2023. Learn the basics to build a solid financial foundation today!
18,336 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Global markets wobble as Iran-related tensions flare, pushing equities toward correction while traders turn to option...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
BlackRock chief executive officer Larry Fink signaled that some AI players will fail as the industry expands, framing...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...
As AI demand grows, one data-center play stands out for potential upside. This piece breaks down the catalysts, risks...
Robot dogs priced $300,000 are stepping into data-center security as AI investment surges. The four-legged guards pro...
Tally, a leading DAO governance tool used by hundreds of communities, will shut down after five years as regulators c...
Prediction markets are flashing recession warnings, but that doesn’t automatically mean investors should panic. This ...
In this analysis, we unpack what Andy Jassy's recent remarks mean for Amazon stock and AWS growth. Learn actionable s...
A fresh take on spotting a possible dark-horse in the driverless vehicle arena. Learn the signals, risks, and how to ...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...